Address of Corresponding Author

Intervirology 2005;48:97-103 (DOI: 10.1159/000081735)

  Key Words

• Nonpolio enterovirus
• Aseptic meningitis
• Serotyping
• Cytopathic effects

  Abstract

Objectives: We attempted to characterize nonpolio enteroviruses recovered from Korean patients with aseptic meningitis. Methods: We performed RT-PCR on the 5'-nontranslated region using clinical specimens. Infectious clinical isolates were amplified by infecting Vero cells with RT-PCR-positive clinical specimens. We then investigated the direct effect in primary neuronal cells or cardiomyocytes following virus infection. Results: Total 12 clinical isolates were subtypically analyzed by both RT-PCR/sequencing comparison of the VP-1 region and neutralization assay. 43-2, 43-2S, 57 and 58 were found to be coxsackievirus B1 (CVB1), 312 to be CVB5, 14-2S and 327 to be echovirus 6, 165 to be echovirus 9, 337 to be echovirus 11, and 270 to be echovirus 30. All the clinical isolates tested showed profound cytotoxicity to various degrees in the primary neuronal cells within 24 h postinfection at 10 MOI. By contrast, a significant cytopathic effect was observed in the primary cardiomyocytes at 3-5 days postinfection at 50 MOI. Conclusions: The present study suggests that the clinical isolates recovered from Korean patients belonged to different CVB or echovirus serotypes and that these viruses showed diversities in their virulence in primary neuronal cells and cardiomyocytes.

Copyright © 2005 S. Karger AG, Basel

  References

1.

Melnick JL: Enteroviruses: Polioviruses, coxsackieviruses, echoviruses and newer enteroviruses; in Fields B, Knipe D, Howley P (eds): Fields Virology. Philadelphia, Lippincott- Raven, 1996, pp 655-712.

2.

Cherry JD: Non-polio enteroviruses: Coxsackieviruses, echoviruses and enteroviruses; in Feigin R, Cherry JD (eds): Textbook of Pediatric Infectious Diseases. Philadelphia, Saunders, 1981, pp 1316-1365.

3.

Roivainen M: Enteroviruses and myocardial infarction. Am Heart J 1999;138:S479-S483.

4.

Muir P: Enteroviruses and heart disease. Br J Biomed Sci 1993;50:258-271.

5.

Morens DM, Zweighaft RM, Bryan JM: Non-polio enterovirus disease in the United States, 1971-1975. Int J Epidemiol 1979;8:49-54.

6.

Asano Y, Yoshikawa T: Enterovirus infections in children. Curr Opin Pediatr 1995;7:24-31.

7.

Zaoutis T, Klein JD: Enterovirus infections. Pediatr Rev 1998;19:183-191.

8.

Nigrovic LE: What's new with enteroviral infections? Curr Opin Pediatr 2001;13:89-94.

9.

Rueckert RR: Picornaviridae: The viruses and their replication; in Fields B, Knipe D, Howley P (eds): Fields Virology. New York, Raven, 1996, pp 609-654.

10.

Andino R, Rieckhof GE, Achacoso PL, Baltimore D: Poliovirus RNA synthesis utilizes an RNP complex formed around the 5'-end of viral RNA. EMBO J 1993;12:3587-3598.

11.

Pelletier J, Kaplan G, Racaniello VR, Sonenberg N: Cap-independent translation of poliovirus mRNA is conferred by sequence elements within the 5' noncoding region. Mol Cell Biol 1988;8:1103-1112.

12.

Hellen CU, Krausslich HG, Wimmer E: Proteolytic processing of polyproteins in the replication of RNA viruses. Biochemistry 1989;28:9881-9890.

13.

Schmidt NJ, Ho HH, Lennette EH: Propagation and isolation of group A coxsackieviruses in RD cells. J Clin Microbiol 1975;2:183-185.

14.

Melnick JL, Schmidt NJ, Hampil B, Ho HH: Lyophilized combination pools of enterovirus equine antisera: Preparation and test procedures for the identification of field strains of 42 enteroviruses. Bull World Health Organ 1973;48:263-268.

15.

Casas I, Palacios GF, Trallero G, Cisterna D, Freire MC, Tenorio A: Molecular characterization of human enteroviruses in clinical samples: Comparison between VP2, VP1, and RNA polymerase regions using RT nested PCR assays and direct sequencing of products. J Med Virol 2001;65:138-148.

16.

Muir P, Kammerer U, Korn K, Mulders MN, Poyry T, Weissbrich B, Kandolf R, Cleator GM, van Loon AM: Molecular typing of enteroviruses: Current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis. Clin Microbiol Rev 1998;11:202-227.

17.

Caro V, Guillot S, Delpeyroux F, Crainic R: Molecular strategy for 'serotyping' of human enteroviruses. J Gen Virol 2001;82:79-91.

18.

Kim DS, Nam JH, Kim KS, Yoon JD, Kim YK: The development of molecular detection method and differentiation of genotypes of enterovirus. J Korean Soc Virol 1997;27:169-176.

19.

Berlin LE, Rorabaugh ML, Heldrich F, Roberts K, Doran T, Modlin JF: Aseptic meningitis in infants <2 years of age: Diagnosis and etiology. J Infect Dis 1993;168:888-892.

20.

Oberste MS, Maher K, Kilpatrick DR, Flemister MR, Brown BA, Pallansch MA: Typing of human enteroviruses by partial sequencing of VP1. J Clin Microbiol 1999;37:1288-1293.

21.

Jung YT, Kim GR, Paik SY: Molecular biological characterization of enterovirus variant isolated from patients with aseptic meningitis. Exp Mol Med 1998;30:101-107.

22.

Rotbart HA, Romero JR: Laboratory diagnosis of enteroviral infections; in Robart H (ed): Human Enterovirus Infections. Washington, ASM Press, 1995, pp 401-408.

23.

Dagan R, Menegus MA: A combination of four cell types for rapid detection of enteroviruses in clinical specimens. J Med Virol 1986;19:219-228.

24.

O'Neill HJ, Russell JD, Wyatt DE, McCaughey C, Coyle PV: Isolation of viruses from clinical specimens in microtitre plates with cells inoculated in suspension. J Virol Methods 1996;62:169-178.

25.

Chonmaitree T, Ford C, Sanders C, Lucia HL: Comparison of cell cultures for rapid isolation of enteroviruses. J Clin Microbiol 1988;26:2576-2580.

26.

Tracy S, Chapman NM, Tu Z: Coxsackievirus B3 from an infectious cDNA copy of the genome is cardiovirulent in mice. Arch Virol 1992;122:399-409.

27.

Chapman NM, Tu Z, Tracy S, Gauntt CJ: An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: Its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses. Arch Virol 1994;135:115-130.

28.

McManus BM, Chow LH, Wilson JE, Anderson DR, Gulizia JM, Gauntt CJ, Klingel KE, Beisel KW, Kandolf R: Direct myocardial injury by enterovirus: A central role in the evolution of murine myocarditis. Clin Immunol Immunopathol 1993;68:159-169.

29.

Chow LH, Beisel KW, McManus BM: Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury. Lab Invest 1992;66:24-31.

30.

Mattson MP, Barger SW, Begley JG, Mark RJ: Calcium, free radicals, and excitotoxic neuronal death in primary cell culture. Methods Cell Biol 1995;46:187-216.

31.

Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.

32.

Decker T, Lohmann-Matthes ML: A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods 1988;115:61-69.

  Author Contacts

Heuiran Lee
Department of Microbiology, University of Ulsan College of Medicine
CPO Box 145
Seoul (Korea)
Tel. +82 2 3010 4286, Fax +82 2 485 2320, E-Mail heuiran@amc.seoul.kr

  Article Information

C.H. Joo and J. Ahn contributed equally to this work.

Received: June 16, 2003
Accepted after revision: March 13, 2004
Number of Print Pages : 7
Number of Figures : 3, Number of Tables : 1, Number of References : 32

  Publication Details

Intervirology (International Journal of Basic and Medical Virology)

Vol. 48, No. 2-3, Year 2005 (Cover Date: March-June 2005)

Journal Editor: U.G. Liebert, Leipzig
ISSN: 0300-5526 (print), 1423-0100 (Online)

For additional information: http://www.karger.com/int

  Drug Dosage / Copyright

Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.